- Home
- AMPG vs ABOS Comparison
AMPG vs ABOS Comparison
Compare AMPG & ABOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMPG
- ABOS
- Stock Information
- Founded
- AMPG 2002
- ABOS 1996
- Country
- AMPG United States
- ABOS United States
- Employees
- AMPG N/A
- ABOS N/A
- Industry
- AMPG Telecommunications Equipment
- ABOS Biotechnology: Pharmaceutical Preparations
- Sector
- AMPG Telecommunications
- ABOS Health Care
- Exchange
- AMPG Nasdaq
- ABOS Nasdaq
- Market Cap
- AMPG 93.8M
- ABOS 103.6M
- IPO Year
- AMPG N/A
- ABOS 2021
- Fundamental
- Price
- AMPG $4.32
- ABOS $1.73
- Analyst Decision
- AMPG
- ABOS Strong Buy
- Analyst Count
- AMPG 0
- ABOS 3
- Target Price
- AMPG N/A
- ABOS $8.00
- AVG Volume (30 Days)
- AMPG 673.0K
- ABOS 370.1K
- Earning Date
- AMPG 11-13-2025
- ABOS 11-11-2025
- Dividend Yield
- AMPG N/A
- ABOS N/A
- EPS Growth
- AMPG N/A
- ABOS N/A
- EPS
- AMPG N/A
- ABOS N/A
- Revenue
- AMPG $19,312,625.00
- ABOS N/A
- Revenue This Year
- AMPG $157.46
- ABOS N/A
- Revenue Next Year
- AMPG $33.33
- ABOS N/A
- P/E Ratio
- AMPG N/A
- ABOS N/A
- Revenue Growth
- AMPG 58.04
- ABOS N/A
- 52 Week Low
- AMPG $0.70
- ABOS $0.86
- 52 Week High
- AMPG $6.43
- ABOS $3.36
- Technical
- Relative Strength Index (RSI)
- AMPG 57.60
- ABOS 66.19
- Support Level
- AMPG $3.78
- ABOS $1.22
- Resistance Level
- AMPG $4.07
- ABOS $1.86
- Average True Range (ATR)
- AMPG 0.34
- ABOS 0.13
- MACD
- AMPG -0.03
- ABOS 0.05
- Stochastic Oscillator
- AMPG 48.65
- ABOS 80.00
About AMPG Amplitech Group Inc.
AmpliTech Group Inc designs, develops, engineers, and assembles micro-wave component-based amplifiers that meet individual customer specifications. The products of the company consist of RF amplifiers & related subsystems, operating at multiple frequencies from 50kHz to 44GHz, including Low Noise Amplifiers, Medium Power Amplifiers, cryogenic amplifiers, and custom assemblies. The company also offers non-recurring engineering services on a project-by-project basis, for a predetermined fixed contractual amount, or on a time-plus-material basis. It also operates as a manufacturer, & distributor of cryogenic microwave amplifiers, RF designs, & applications for Wireless Networks & the future of Wireless Communication.
About ABOS Acumen Pharmaceuticals Inc.
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers.